|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/25/19 AVROBIO, Inc. 10-K 12/31/18 85:7.2M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.06M
2: EX-10.13 Material Contract HTML 84K
3: EX-10.14 Material Contract HTML 61K
4: EX-10.15 Material Contract HTML 90K
5: EX-21.1 Subsidiaries List HTML 24K
6: EX-23.1 Consent of Experts or Counsel HTML 25K
7: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
8: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
9: EX-32.1 Certification -- §906 - SOA'02 HTML 28K
16: R1 Document and Entity Information HTML 63K
17: R2 Consolidated Balance Sheets HTML 94K
18: R3 Consolidated Balance Sheets (Parenthetical) HTML 45K
19: R4 Consolidated Statements of Operations and HTML 68K
Comprehensive Loss
20: R5 Consolidated Statements of Redeemable Convertible HTML 98K
Preferred Stock and Stockholders' (Deficit) Equity
21: R6 Consolidated Statements of Redeemable Convertible HTML 30K
Preferred Stock and Stockholders' (Deficit) Equity
(Parenthetical)
22: R7 Consolidated Statements of Cash Flows HTML 111K
23: R8 Nature of the Business HTML 34K
24: R9 Summary of Significant Accounting Policies HTML 112K
25: R10 Fair Value of Financial Assets and Liabilities HTML 64K
26: R11 Prepaid Expenses and Other Current Assets HTML 33K
27: R12 Property and Equipment, Net HTML 34K
28: R13 Accrued Expenses HTML 33K
29: R14 Loan Agreement and Warrant to Purchase Preferred HTML 33K
Stock
30: R15 Redeemable Convertible Preferred Stock HTML 41K
31: R16 Common Stock HTML 46K
32: R17 Stock-Based Compensation HTML 71K
33: R18 License Agreements HTML 53K
34: R19 Income Taxes HTML 64K
35: R20 Net Loss per Share Attributable to Common HTML 34K
Stockholders
36: R21 Commitments and Contingencies HTML 43K
37: R22 Related Party Transactions HTML 37K
38: R23 Benefit Plans HTML 31K
39: R24 Subsequent Events HTML 29K
40: R25 Summary of Significant Accounting Policies HTML 157K
(Policies)
41: R26 Summary of Significant Accounting Policies HTML 36K
(Tables)
42: R27 Fair Value of Financial Assets and Liabilities HTML 64K
(Tables)
43: R28 Prepaid Expenses and Other Current Assets (Tables) HTML 34K
44: R29 Property and Equipment, Net (Tables) HTML 34K
45: R30 Accrued Expenses (Tables) HTML 32K
46: R31 Redeemable Convertible Preferred Stock (Tables) HTML 36K
47: R32 Common Stock (Tables) HTML 43K
48: R33 Stock-Based Compensation (Tables) HTML 62K
49: R34 Income Taxes (Tables) HTML 52K
50: R35 Net Loss per Share Attributable to Common HTML 33K
Stockholders (Tables)
51: R36 Commitments and Contingencies (Tables) HTML 33K
52: R37 Nature of the Business - Additional Information HTML 38K
(Detail)
53: R38 Summary of Significant Accounting Policies - HTML 44K
Additional Information (Detail)
54: R39 Summary of Significant Accounting Policies - HTML 36K
Estimated Useful Lives of Property and Equipment
(Detail)
55: R40 Summary of Significant Accounting Policies - HTML 38K
Statements of cash flows subsequent to the
adoption of ASU (Detail)
56: R41 Fair Value of Financial Assets and Liabilities - HTML 51K
Summary of Financial Assets and Liabilities
Measured at Fair Value on Recurring Basis (Detail)
57: R42 Fair Value of Financial Assets and Liabilities - HTML 48K
Additional Information (Detail)
58: R43 Fair Value of Financial Assets and Liabilities - HTML 39K
Summary of Changes in Fair Value of Preferred
Stock Warrant Liability for Fair Value Determined
by Level 3 Inputs (Detail)
59: R44 Fair Value of Financial Assets and Liabilities - HTML 37K
Summary of Changes in Fair Value of Derivative
Liability for Fair Value Determined by Level 3
Inputs (Detail)
60: R45 Prepaid Expenses and Other Current Assets - HTML 45K
Summary of Prepaid Expenses and Other Current
Assets (Detail)
61: R46 Property and Equipment, Net - Summary of Property HTML 42K
and Equipment, Net (Detail)
62: R47 Property and Equipment, Net - Additional HTML 29K
Information (Detail)
63: R48 Accrued Expenses - Summary of Accrued Expenses and HTML 41K
Other Current Liabilities (Detail)
64: R49 Loan Agreement and Warrant to Purchase Preferred HTML 61K
Stock - Additional Information (Detail)
65: R50 Redeemable Convertible Preferred Stock - HTML 81K
Additional Information (Detail)
66: R51 Redeemable Convertible Preferred Stock - Summary HTML 59K
of Preferred Stock (Detail)
67: R52 Common Stock - Additional Information (Detail) HTML 66K
68: R53 Common Stock - Summary of Common Stock Reserved HTML 44K
for Future Issuance (Detail)
69: R54 Stock-Based Compensation - Additional Information HTML 66K
(Detail)
70: R55 Stock-Based Compensation - Summary of Assumptions HTML 37K
that Used to Determine Grant-Date Fair Value of
Stock Options Granted to Employees and Members of
Board (Detail)
71: R56 Stock-Based Compensation - Summary of Stock Option HTML 72K
Activity (Detail)
72: R57 Stock-Based Compensation - Summary of Restricted HTML 40K
Stock Unit Activity (Detail)
73: R58 Stock-Based Compensation - Schedule of Stock-based HTML 34K
Compensation Expense (Detail)
74: R59 License Agreements - Additional Information HTML 83K
(Detail)
75: R60 Income Taxes - Additional Information (Detail) HTML 79K
76: R61 Income Taxes - Schedule of Reconciliation of HTML 54K
Income Tax Expense (Benefit) (Detail)
77: R62 Income Taxes - Schedule of Deferred Tax Assets and HTML 60K
Liabilities (Detail)
78: R63 Net Loss per Share - Schedule of Dilutive Common HTML 38K
Stock Equivalents Excluded from Computation of
Diluted Net Loss per Share (Detail)
79: R64 Commitments and Contingencies - Additional HTML 42K
Information (Detail)
80: R65 Commitments and Contingencies - Schedule Of Future HTML 43K
Minimum Rental Payment Under Operating Lease
(Detail)
81: R66 Related Party Transactions - Additional HTML 66K
information (Detail)
82: R67 Benefit Plans - Additional Information (Detail) HTML 30K
84: XML IDEA XML File -- Filing Summary XML 152K
83: EXCEL IDEA Workbook of Financial Reports XLSX 87K
10: EX-101.INS XBRL Instance -- avro-20181231 XML 1.21M
12: EX-101.CAL XBRL Calculations -- avro-20181231_cal XML 169K
13: EX-101.DEF XBRL Definitions -- avro-20181231_def XML 511K
14: EX-101.LAB XBRL Labels -- avro-20181231_lab XML 1.25M
15: EX-101.PRE XBRL Presentations -- avro-20181231_pre XML 884K
11: EX-101.SCH XBRL Schema -- avro-20181231 XSD 187K
85: ZIP XBRL Zipped Folder -- 0001193125-19-085321-xbrl Zip 162K
| EX-31.1 |
Exhibit 31.1
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Geoff MacKay, certify that:
1. I have reviewed this Annual Report on Form 10-K of AVROBIO, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| Date: March 25, 2019 | By: | /s/ Geoff MacKay | ||||
| Geoff MacKay | ||||||
| Chief Executive Officer (Principal Executive Officer) |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/25/19 | 8-K, S-8 | ||
| For Period end: | 12/31/18 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/29/24 AVROBIO, Inc. S-4/A 80:15M Donnelley … Solutions/FA 4/15/24 AVROBIO, Inc. S-4/A 91:17M Donnelley … Solutions/FA 3/26/24 AVROBIO, Inc. S-4/A 3/25/24 89:18M Donnelley … Solutions/FA 3/14/24 AVROBIO, Inc. 10-K 12/31/23 80:9.4M Donnelley … Solutions/FA 2/14/24 AVROBIO, Inc. S-4 91:25M Donnelley … Solutions/FA 3/23/23 AVROBIO, Inc. 10-K 12/31/22 82:10M Donnelley … Solutions/FA 3/17/22 AVROBIO, Inc. 10-K 12/31/21 78:9.1M ActiveDisclosure/FA 3/18/21 AVROBIO, Inc. 10-K 12/31/20 73:9.1M ActiveDisclosure/FA 11/20/20 AVROBIO, Inc. 424B5 1:5.2M Donnelley … Solutions/FA 11/19/20 AVROBIO, Inc. 424B5 1:5.1M Donnelley … Solutions/FA |